Longitudinal Dynamics of the Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

BACKGROUND: Coronavirus disease 2019 (COVID-19) is a global pandemic with no licensed vaccine or specific antiviral agents for therapy. Little is known about the longitudinal dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–specific neutralizing antibodies (NAbs) in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kai, Long, Quan-Xin, Deng, Hai-Jun, Hu, Jie, Gao, Qing-Zhu, Zhang, Gui-Ji, He, Chang-Long, Huang, Lu-Yi, Hu, Jie-Li, Chen, Juan, Tang, Ni, Huang, Ai-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454328/
https://www.ncbi.nlm.nih.gov/pubmed/32745196
http://dx.doi.org/10.1093/cid/ciaa1143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454328/
https://www.ncbi.nlm.nih.gov/pubmed/32745196
http://dx.doi.org/10.1093/cid/ciaa1143

Ejemplares similares